ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Oxford Biomedica to license LentiVector to Juno pharmatimes
March 19, 2020Oxford Biomedica has signed a Licence and Clinical Supply Agreement (LSA) with Bristol-Myers Squibb’s Juno Theraputics, granting the latter a non-exclusive license to the?LentiVector?platform.
Pharma Sources Insight January 2025
